Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Head and Neck Cancer

  Free Subscription

Articles published in Cancer

Retrieve available abstracts of 232 articles:
HTML format

Single Articles

    August 2021
  1. SEAMAN AT, Seligman KL, Nguyen KK, Al-Qurayshi Z, et al
    Characterizing head and neck cancer survivors' discontinuation of survivorship care.
    Cancer. 2021 Aug 30. doi: 10.1002/cncr.33888.
    PubMed     Abstract available

  2. HARDMAN JC, Tikka T, Paleri V
    Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study.
    Cancer. 2021 Aug 19. doi: 10.1002/cncr.33800.
    PubMed     Abstract available

  3. CHERA BS, Sheth SH, Patel SA, Goldin D, et al
    Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinoma.
    Cancer. 2021 Aug 11. doi: 10.1002/cncr.33789.
    PubMed     Abstract available

  4. AMIT M, Liu C, Mansour J, Gleber-Netto FO, et al
    Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma.
    Cancer. 2021 Aug 6. doi: 10.1002/cncr.33773.
    PubMed     Abstract available

    July 2021
  5. YU KJ, Hsu WL, Chiang CJ, Chen TC, et al
    Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years.
    Cancer. 2021 Jul 29. doi: 10.1002/cncr.33799.
    PubMed     Abstract available

  6. LIU Z, Li H, Yu KJ, Xie SH, et al
    Comparison of new magnetic resonance imaging grading system with conventional endoscopy for the early detection of nasopharyngeal carcinoma.
    Cancer. 2021 Jul 7. doi: 10.1002/cncr.33552.
    PubMed     Abstract available

    June 2021
  7. FU TS, Scheffler P, Forner D, Noel CW, et al
    A cost-utility analysis comparing CT surveillance, PET-CT surveillance, and planned postradiation neck dissection for advanced nodal HPV-positive oropharyngeal cancer.
    Cancer. 2021 Jun 1. doi: 10.1002/cncr.33653.
    PubMed     Abstract available

    May 2021
  8. RUAN X, Liang JH, Pan Y, Cai R, et al
    Apatinib for the treatment of metastatic or locoregionally recurrent nasopharyngeal carcinoma after failure of chemotherapy: A multicenter, single-arm, prospective phase 2 study.
    Cancer. 2021 May 27. doi: 10.1002/cncr.33626.
    PubMed     Abstract available

  9. XIAO C, Beitler JJ, Peng G, Levine ME, et al
    Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study.
    Cancer. 2021 May 24. doi: 10.1002/cncr.33641.
    PubMed     Abstract available

  10. WEISS JM
    Surgery alone for transorally resected human papillomavirus-driven head and neck cancer-Can we de-intensify adjuvant therapy to 0 Gy and 0 mg/m(2) ?
    Cancer. 2021 May 6. doi: 10.1002/cncr.33610.
    PubMed     Abstract available

    April 2021
  11. CHEN Y, Chang ET, Liu Q, Cai Y, et al
    Occupational exposures and risk of nasopharyngeal carcinoma in a high-risk area: A population-based case-control study.
    Cancer. 2021 Apr 6. doi: 10.1002/cncr.33536.
    PubMed     Abstract available

    Racial disparity in head and neck cancer.
    Cancer. 2021 Apr 2. doi: 10.1002/cncr.33555.

  13. VOORA RS, Kotha NV, Kumar A, Qiao EM, et al
    Association of Race and Health Care System With Disease Stage and Survival in Veterans With Larynx Cancer.
    Cancer. 2021 Apr 2. doi: 10.1002/cncr.33557.
    PubMed     Abstract available

    February 2021
  14. DE BREE R, de Keizer B
    Comparison of different diagnostic approaches in the management of the clinically negative neck in early oral cancer patients.
    Cancer. 2021 Feb 26. doi: 10.1002/cncr.33443.

  15. NOEL CW, Forner D, Goldstein DP, Metser U, et al
    Elective neck dissection versus positron emission tomography-computed tomography-guided management of the neck in clinically node-negative early oral cavity cancer: A cost-utility analysis.
    Cancer. 2021 Feb 26. doi: 10.1002/cncr.33446.
    PubMed     Abstract available

  16. KIONG KL, Yao CMKL, Lin FY, Bell D, et al
    Delay to surgery after neoadjuvant chemotherapy in head and neck squamous cell carcinoma affects oncologic outcomes.
    Cancer. 2021 Feb 25. doi: 10.1002/cncr.33471.
    PubMed     Abstract available

  17. SHEWALE JB, Pickard RKL, Xiao W, Jiang B, et al
    Independent association of marijuana use and poor oral hygiene with HPV-negative but not HPV-positive head and neck squamous cell carcinomas.
    Cancer. 2021 Feb 23. doi: 10.1002/cncr.33440.
    PubMed     Abstract available

  18. WANG SM, Freedman ND, Katki HA, Matthews C, et al
    Gastroesophageal reflux disease: A risk factor for laryngeal squamous cell carcinoma and esophageal squamous cell carcinoma in the NIH-AARP Diet and Health Study cohort.
    Cancer. 2021 Feb 22. doi: 10.1002/cncr.33427.
    PubMed     Abstract available

    Head and neck cancer staging: Balancing innovation with consistency.
    Cancer. 2021 Feb 17. doi: 10.1002/cncr.33415.

  20. PRINTZ C
    Study adds evidence to link between gum disease and cancer risk: Researchers observe connection with gastric, esophageal cancer.
    Cancer. 2021;127:495-496.

    January 2021
  21. YAO CMKL, Fu S, Tam S, Kiong KL, et al
    Impact of provider type and number of providers on surveillance testing among survivors of head and neck cancers.
    Cancer. 2021 Jan 20. doi: 10.1002/cncr.33402.
    PubMed     Abstract available

  22. LIN YT, Wang HC, Tsai MH, Su YY, et al
    Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K/AKT signaling in nasopharyngeal carcinoma.
    Cancer. 2021 Jan 6. doi: 10.1002/cncr.33391.
    PubMed     Abstract available

    December 2020

  23. Head and neck cancer surgery during the COVID-19 pandemic: An international, multicenter, observational cohort study.
    Cancer. 2020 Dec 21. doi: 10.1002/cncr.33320.
    PubMed     Abstract available

  24. AMIT M, Liu C, Gleber-Netto FO, Kini S, et al
    Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck.
    Cancer. 2020 Dec 15. doi: 10.1002/cncr.33373.
    PubMed     Abstract available

    November 2020
  25. KAWASAKI M, Ikeda Y, Ikeda E, Takahashi M, et al
    Oral infectious bacteria in dental plaque and saliva as risk factors in patients with esophageal cancer.
    Cancer. 2020 Nov 6. doi: 10.1002/cncr.33316.
    PubMed     Abstract available

    October 2020
  26. MORGAN RL, Eguchi MM, McDermott J, Mueller AC, et al
    Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer.
    Cancer. 2020 Oct 29. doi: 10.1002/cncr.33244.
    PubMed     Abstract available

  27. LIU W, Qdaisat A, Ferrarotto R, Fuller CD, et al
    Hypomagnesemia and survival in patients with head and neck cancers who received primary concurrent chemoradiation.
    Cancer. 2020 Oct 21. doi: 10.1002/cncr.33283.
    PubMed     Abstract available

  28. SWIECICKI PL, Bellile EL, Brummel CV, Brenner JC, et al
    Efficacy of axitinib in metastatic head and neck cancer with novel radiographic response criteria.
    Cancer. 2020 Oct 20. doi: 10.1002/cncr.33226.
    PubMed     Abstract available

  29. ZHANG N, Li Y, Chang X, Lei F, et al
    Long-term effectiveness of one-time endoscopic screening for esophageal cancer: A community-based study in rural China.
    Cancer. 2020;126:4511-4520.
    PubMed     Abstract available

  30. ZAKERI K, Rotolo F, Lacas B, Vitzthum LK, et al
    Predictive classifier for intensive treatment of head and neck cancer.
    Cancer. 2020 Oct 5. doi: 10.1002/cncr.33212.
    PubMed     Abstract available

    September 2020
  31. G V REDDY N, Singh A, Subash A
    Preservation of spinal accessory and level 2b-sparing neck dissection: The balance beyond oncology and functionality.
    Cancer. 2020 Sep 17. doi: 10.1002/cncr.33166.

    Reply to Preservation of spinal accessory and level 2b-sparing neck dissection: The balance beyond oncology and functionality.
    Cancer. 2020 Sep 17. doi: 10.1002/cncr.33164.

  33. HU J, Huang Q, Gao J, Guan X, et al
    Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Cancer. 2020 Sep 15. doi: 10.1002/cncr.33197.
    PubMed     Abstract available

  34. REYES-GIBBY CC, Wang J, Zhang L, Peterson CB, et al
    Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck.
    Cancer. 2020 Sep 5. doi: 10.1002/cncr.33161.
    PubMed     Abstract available

    August 2020
  35. DE ALMEIDA JR, Noel CW, Forner D, Zhang H, et al
    Development and validation of a surgical prioritization and ranking tool and navigation aid for head and neck cancer (SPARTAN-HN) in a scarce resource setting: Response to the COVID-19 pandemic.
    Cancer. 2020 Aug 11. doi: 10.1002/cncr.33114.
    PubMed     Abstract available

  36. HONG MH, Heo SG, Lee YG, Kim HS, et al
    Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma.
    Cancer. 2020 Aug 4. doi: 10.1002/cncr.33123.
    PubMed     Abstract available

    July 2020
  37. KIONG KL, Lin FY, Yao CMKL, Guo T, et al
    Impact of neoadjuvant chemotherapy on perioperative morbidity after major surgery for head and neck cancer.
    Cancer. 2020 Jul 24. doi: 10.1002/cncr.33103.
    PubMed     Abstract available

  38. SAITO Y, Hayashi R, Iida Y, Mizumachi T, et al
    Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national head and neck cancer registry of Japan.
    Cancer. 2020 Jul 10. doi: 10.1002/cncr.33062.
    PubMed     Abstract available

  39. KANG JJ, Wong RJ, Sherman EJ, Rybkin A, et al
    The 3 B's of cancer care amid the COVID-19 pandemic crisis: "Be safe, be smart, be kind"-A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer.
    Cancer. 2020 Jul 8. doi: 10.1002/cncr.33031.
    PubMed     Abstract available

  40. SCHUTTE HW, van den Broek GB, Steens SCA, Hermens RPMG, et al
    Impact of optimizing diagnostic workup and reducing the time to treatment in head and neck cancer.
    Cancer. 2020 Jul 7. doi: 10.1002/cncr.33037.
    PubMed     Abstract available

    June 2020
  41. HUENIKEN K, Douglas CM, Jethwa AR, Mirshams M, et al
    Measuring financial toxicity incurred after treatment of head and neck cancer: Development and validation of the Financial Index of Toxicity questionnaire.
    Cancer. 2020 Jun 30. doi: 10.1002/cncr.33032.
    PubMed     Abstract available

  42. BROUGHMAN JR, Xiong DD, Moeller BJ, Contrera KJ, et al
    Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysis.
    Cancer. 2020;126:2784-2790.
    PubMed     Abstract available

  43. LEE AWM, Ngan RKC, Ng WT, Tung SY, et al
    NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma.
    Cancer. 2020 Jun 4. doi: 10.1002/cncr.32972.
    PubMed     Abstract available

  44. CAVALIERI S, Licitra L
    Induction chemotherapy is the best timekeeper in nasopharyngeal carcinoma.
    Cancer. 2020 Jun 4. doi: 10.1002/cncr.32971.

  45. HUANG SH, O'Sullivan B, Su J, Ringash J, et al
    Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
    Cancer. 2020 Jun 1. doi: 10.1002/cncr.32968.
    PubMed     Abstract available

  46. LANG KUHS KA, Wood CB, Wiggleton J, Aulino JM, et al
    Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer.
    Cancer. 2020;126:2658-2665.
    PubMed     Abstract available

    May 2020
  47. MIMICA X, McGill M, Hay A, Karassawa Zanoni D, et al
    Distant metastasis of salivary gland cancer: Incidence, management, and outcomes.
    Cancer. 2020;126:2153-2162.
    PubMed     Abstract available

  48. SEIWERT TY, Kochanny S, Wood K, Worden FP, et al
    A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.
    Cancer. 2020 May 4. doi: 10.1002/cncr.32929.
    PubMed     Abstract available

    April 2020
  49. PRINTZ C
    Radiation from computed tomography scans is associated with increased risk for thyroid cancer and leukemia.
    Cancer. 2020;126:1601.

  50. BIGELOW EO, Blackford AL, Eytan DF, Eisele DW, et al
    Burden of comorbidities is higher among elderly survivors of oropharyngeal cancer compared with controls.
    Cancer. 2020;126:1793-1803.
    PubMed     Abstract available

  51. FULLERTON ZH, Butler SS, Mahal BA, Muralidhar V, et al
    Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status.
    Cancer. 2020;126:1424-1433.
    PubMed     Abstract available

  52. OLIVER JR, Lieberman SM, Tam MM, Liu CZ, et al
    Human papillomavirus and survival of patients with sinonasal squamous cell carcinoma.
    Cancer. 2020;126:1413-1423.
    PubMed     Abstract available

  53. HERMANN GM, Iovoli AJ, Platek AJ, Wang C, et al
    A single-institution, randomized, pilot study evaluating the efficacy of gabapentin and methadone for patients undergoing chemoradiation for head and neck squamous cell cancer.
    Cancer. 2020;126:1480-1491.
    PubMed     Abstract available

    March 2020
  54. ZHAN KY, Puram SV, Li MM, Silverman DA, et al
    National treatment trends in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2020;126:1295-1305.
    PubMed     Abstract available

  55. CHEN FP, Huang XD, Lv JW, Wen DW, et al
    Prognostic potential of liquid biopsy tracking in the posttreatment surveillance of patients with nonmetastatic nasopharyngeal carcinoma.
    Cancer. 2020 Mar 3. doi: 10.1002/cncr.32770.
    PubMed     Abstract available

  56. VALERO C, Zanoni DK, McGill MR, Ganly I, et al
    Pretreatment peripheral blood leukocytes are independent predictors of survival in oral cavity cancer.
    Cancer. 2020;126:994-1003.
    PubMed     Abstract available

    February 2020
  57. MROZ EA, Patel KB, Rocco JW
    Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.
    Cancer. 2020 Feb 21. doi: 10.1002/cncr.32742.
    PubMed     Abstract available

  58. KOCHANNY SE, Worden FP, Adkins DR, Lim DW, et al
    A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
    Cancer. 2020 Feb 19. doi: 10.1002/cncr.32762.
    PubMed     Abstract available

  59. BASAK SK, Bera A, Yoon AJ, Morselli M, et al
    A randomized, phase 1, placebo-controlled trial of APG-157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor-associated microbes.
    Cancer. 2020 Feb 5. doi: 10.1002/cncr.32644.
    PubMed     Abstract available

    January 2020
  60. GULATI S, Desai J, Palackdharry SM, Morris JC, et al
    Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer.
    Cancer. 2020;126:354-362.
    PubMed     Abstract available

  61. TIAN S, Jiang R, Madden NA, Ferris MJ, et al
    Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy.
    Cancer. 2020;126:37-45.
    PubMed     Abstract available

  62. FREITAG J, Wald T, Kuhnt T, Gradistanac T, et al
    Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2020;126:1856-1872.
    PubMed     Abstract available

  63. RODEN DF, Hobelmann K, Vimawala S, Richa T, et al
    Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery.
    Cancer. 2020;126:1873-1887.
    PubMed     Abstract available

  64. XIAO Q, Li Z, Ji J
    Patients with gastroesophageal junction adenocarcinomas of an advanced stage may benefit from perioperative chemoradiotherapy: A validation based on the Surveillance, Epidemiology, and End Results database.
    Cancer. 2020;126:2036-2037.

  65. FAN M, Kang JJ, Lee A, Fan D, et al
    Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies.
    Cancer. 2020;126:1905-1916.
    PubMed     Abstract available

  66. LOCATI LD, Galbiati D, Calareso G, Alfieri S, et al
    Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life.
    Cancer. 2020;126:1888-1894.
    PubMed     Abstract available

    December 2019
  67. DZIEGIELEWSKI PT, McNeely ML, Ashworth N, O'Connell DA, et al
    2b or not 2b? Shoulder function after level 2b neck dissection: A double-blind randomized controlled clinical trial.
    Cancer. 2019 Dec 24. doi: 10.1002/cncr.32681.
    PubMed     Abstract available

  68. CHEN DW, Reyes-Gastelum D, Wallner LP, Papaleontiou M, et al
    Disparities in risk perception of thyroid cancer recurrence and death.
    Cancer. 2019 Dec 23. doi: 10.1002/cncr.32670.
    PubMed     Abstract available

  69. CHEN YY, Wang CC, Wu WT, Lai CH, et al
    Trajectories of returning to work and its impact on survival in survivors with oral cancer: A 5-year follow-up study.
    Cancer. 2019 Dec 6. doi: 10.1002/cncr.32643.
    PubMed     Abstract available

    November 2019
  70. NG SP, Ajayi T, Schaefer AJ, Pollard C 3rd, et al
    Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process model.
    Cancer. 2019 Nov 14. doi: 10.1002/cncr.32597.
    PubMed     Abstract available

  71. THOMPSON-HARVEY A, Yetukuri M, Hansen AR, Simpson MC, et al
    Rising incidence of late-stage head and neck cancer in the United States.
    Cancer. 2019 Nov 13. doi: 10.1002/cncr.32583.
    PubMed     Abstract available

  72. KAWAKITA D, Abdelaziz S, Chen Y, Rowe K, et al
    Adverse respiratory outcomes among head and neck cancer survivors in the Utah Cancer Survivors Study.
    Cancer. 2019 Nov 13. doi: 10.1002/cncr.32617.
    PubMed     Abstract available

  73. LIU C, Guo T, Sakai A, Ren S, et al
    A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
    Cancer. 2019 Nov 13. doi: 10.1002/cncr.32610.
    PubMed     Abstract available

    October 2019
  74. FAN D, Ma J, Bell AC, Groen AH, et al
    Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
    Cancer. 2019 Oct 8. doi: 10.1002/cncr.32548.
    PubMed     Abstract available

  75. NOCON CC, Ajmani GS, Bhayani MK
    A contemporary analysis of racial disparities in recommended and received treatment for head and neck cancer.
    Cancer. 2019 Oct 3. doi: 10.1002/cncr.32342.
    PubMed     Abstract available

  76. PRINTZ C
    First person profile: Albert de la Chapelle, MD, PhD: Known for several pioneering discoveries in genetics, Dr. de la Chapelle is working to shed light on the genes that cause thyroid cancer.
    Cancer. 2019;125:3285-3286.

    September 2019
  77. LIN C, Cao SM, Chang ET, Liu Z, et al
    Chinese nonmedicinal herbal diet and risk of nasopharyngeal carcinoma: A population-based case-control study.
    Cancer. 2019 Sep 22. doi: 10.1002/cncr.32458.
    PubMed     Abstract available

  78. YOSHIDA EJ, Luu M, Mallen-St Clair J, Mita AC, et al
    Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
    Cancer. 2019 Sep 19. doi: 10.1002/cncr.32501.
    PubMed     Abstract available

  79. ARGIRION I, Zarins KR, Ruterbusch JJ, Vatanasapt P, et al
    Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.
    Cancer. 2019 Sep 16. doi: 10.1002/cncr.32517.
    PubMed     Abstract available

    August 2019
  80. AMENABAR JM, Torres-Pereira CC, Tang KD, Punyadeera C, et al
    Two enemies, one fight: An update of oral cancer in patients with Fanconi anemia.
    Cancer. 2019 Aug 7. doi: 10.1002/cncr.32435.
    PubMed     Abstract available

    July 2019
  81. SHAO D, Vogtmann E, Liu A, Qin J, et al
    Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China.
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32403.
    PubMed     Abstract available

  82. BERNIER MO, Kitahara CM, Shiels MS
    Reply to Natural history of thyroid cancer suggests beginning of the overdiagnosis of juvenile thyroid cancer in the United States and Harm of overdiagnosis or extremely early diagnosis behind trends in pediatric thyroid cancer.
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32425.

  83. MIDORIKAWA S, Murakami M, Ohtsuru A
    Harm of overdiagnosis or extremely early diagnosis behind trends in pediatric thyroid cancer.
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32426.

  84. TAKANO T
    Natural history of thyroid cancer suggests beginning of the overdiagnosis of juvenile thyroid cancer in the United States.
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32424.

  85. SASAKI CT, Doukas SG, Costa J, Vageli DP, et al
    Biliary reflux as a causal factor in hypopharyngeal carcinoma: New clinical evidence and implications.
    Cancer. 2019 Jul 16. doi: 10.1002/cncr.32369.
    PubMed     Abstract available

  86. PRINTZ C
    First person profile: William C. Faquin, MD, PhD: This Harvard pathologist has helped to standardize how certain tumors are tested and diagnosed.
    Cancer. 2019;125:2145-2146.

  87. CLEARY JM, Horick NK, McCleary NJ, Abrams TA, et al
    FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial.
    Cancer. 2019;125:2213-2221.
    PubMed     Abstract available

    June 2019
  88. HADDAD R, Concha-Benavente F, Blumenschein G Jr, Fayette J, et al
    Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.
    Cancer. 2019 Jun 27. doi: 10.1002/cncr.32190.
    PubMed     Abstract available

  89. KIM M, Kim BH, Kim JM, Kim EH, et al
    Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinoma.
    Cancer. 2019 Jun 19. doi: 10.1002/cncr.32166.
    PubMed     Abstract available

  90. PATEL SA, Qureshi MM, Dyer MA, Jalisi S, et al
    Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Cancer. 2019 Jun 17. doi: 10.1002/cncr.32292.
    PubMed     Abstract available

  91. GREALLY M, Agarwal R, Ilson DH
    Optimal management of gastroesophageal junction cancer.
    Cancer. 2019;125:1990-2001.
    PubMed     Abstract available

  92. SHERMAN EJ, Dunn LA, Schoder H, Ho AL, et al
    Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer.
    Cancer. 2019 Jun 7. doi: 10.1002/cncr.32046.
    PubMed     Abstract available

    May 2019
  93. PATIL VM, Noronha V, Joshi A, Agarwal J, et al
    A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
    Cancer. 2019 May 31. doi: 10.1002/cncr.32179.
    PubMed     Abstract available

  94. PARK A, Alabaster A, Shen H, Mell LK, et al
    Undertreatment of women with locoregionally advanced head and neck cancer.
    Cancer. 2019 May 15. doi: 10.1002/cncr.32187.
    PubMed     Abstract available

  95. GRANT S, Kamal M, Mohamed ASR, Zaveri J, et al
    Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing.
    Cancer. 2019;125:1654-1664.
    PubMed     Abstract available

  96. LIN TA, Garden AS, Elhalawani H, Elgohari B, et al
    Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
    Cancer. 2019;125:1536-1546.
    PubMed     Abstract available

    April 2019
  97. ROLLO F, Pichi B, Benevolo M, Giuliani M, et al
    Oral testing for high-risk human papillomavirus DNA and E6/E7 messenger RNA in healthy individuals at risk for oral infection.
    Cancer. 2019 Apr 29. doi: 10.1002/cncr.32152.
    PubMed     Abstract available

  98. TIAN S, Switchenko JM, Jhaveri J, Cassidy RJ, et al
    Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base.
    Cancer. 2019 Apr 23. doi: 10.1002/cncr.32115.
    PubMed     Abstract available

    We cannot ignore the real component of the rise in thyroid cancer incidence.
    Cancer. 2019 Apr 23. doi: 10.1002/cncr.32123.

  100. CHEN AY, Davies L
    Children and thyroid cancer: Interpreting troubling trends.
    Cancer. 2019 Apr 23. doi: 10.1002/cncr.32124.

  101. BERNIER MO, Withrow DR, Berrington de Gonzalez A, Lam CJK, et al
    Trends in pediatric thyroid cancer incidence in the United States, 1998-2013.
    Cancer. 2019 Apr 23. doi: 10.1002/cncr.32125.
    PubMed     Abstract available

    March 2019
  102. FAKHRY C, Zhang Q, Gillison ML, Nguyen-Tan PF, et al
    Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials.
    Cancer. 2019 Mar 26. doi: 10.1002/cncr.32025.
    PubMed     Abstract available

  103. BEITLER JJ, Switchenko JM, Dignam JJ, McDonald MW, et al
    Smoking, age, nodal disease, T stage, p16 status, and risk of distant metastases in patients with squamous cell cancer of the oropharynx.
    Cancer. 2019;125:704-711.
    PubMed     Abstract available

  104. FARAJI F, Rettig EM, Tsai HL, El Asmar M, et al
    The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.
    Cancer. 2019;125:761-769.
    PubMed     Abstract available

    February 2019
  105. NG SP, Pollard C 3rd, Berends J, Ayoub Z, et al
    Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.
    Cancer. 2019 Feb 12. doi: 10.1002/cncr.31983.
    PubMed     Abstract available

  106. LEE NCJ, Kelly JR, An Y, Park HS, et al
    Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma.
    Cancer. 2019 Feb 12. doi: 10.1002/cncr.32001.
    PubMed     Abstract available

    January 2019
  107. MONDACA S, Janjigian YY
    Application of positron emission tomography imaging to personalize esophagogastric cancer care.
    Cancer. 2019 Jan 22. doi: 10.1002/cncr.31940.

  108. WINDON MJ, D'Souza G, Faraji F, Troy T, et al
    Priorities, concerns, and regret among patients with head and neck cancer.
    Cancer. 2019 Jan 15. doi: 10.1002/cncr.31920.
    PubMed     Abstract available

  109. DING DC, Chen W, Wang JH, Lin SZ, et al
    Thyroid cancer risk in women with infertility and association with fertility medications in Taiwan.
    Cancer. 2019 Jan 15. doi: 10.1002/cncr.31964.
    PubMed     Abstract available

  110. BEESLEY LJ, Hawkins PG, Amlani LM, Bellile EL, et al
    Individualized survival prediction for patients with oropharyngeal cancer in the human papillomavirus era.
    Cancer. 2019;125:68-78.
    PubMed     Abstract available

    December 2018
  111. JIANG C, Wang H, Xia C, Dong Q, et al
    A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma.
    Cancer. 2018 Dec 6. doi: 10.1002/cncr.31907.
    PubMed     Abstract available

  112. BADR H, Herbert K, Chhabria K, Sandulache VC, et al
    Self-management intervention for head and neck cancer couples: Results of a randomized pilot trial.
    Cancer. 2018 Dec 6. doi: 10.1002/cncr.31906.
    PubMed     Abstract available

    November 2018
  113. CRACCHIOLO JR, Klassen AF, Young-Afat DA, Albornoz CR, et al
    Leveraging patient-reported outcomes data to inform oncology clinical decision making: Introducing the FACE-Q head and neck cancer module.
    Cancer. 2018 Nov 30. doi: 10.1002/cncr.31900.
    PubMed     Abstract available

  114. EYTAN DF, Blackford AL, Eisele DW, Fakhry C, et al
    Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.
    Cancer. 2018 Nov 16. doi: 10.1002/cncr.31800.
    PubMed     Abstract available

  115. GREALLY M, Ilson DH
    Neoadjuvant therapy for esophageal cancer: Who, when, and what?
    Cancer. 2018;124:4276-4278.

    October 2018
  116. HARADA K, Pool Pizzi M, Baba H, Shanbhag ND, et al
    Cancer stem cells in esophageal cancer and response to therapy.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31697.

  117. GUO R, Tang LL, Mao YP, Du XJ, et al
    Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
    Cancer. 2018 Oct 23. doi: 10.1002/cncr.31741.
    PubMed     Abstract available

  118. THAM T
    Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: Multicenter study from an endemic area in Southern China.
    Cancer. 2018 Oct 21. doi: 10.1002/cncr.31819.

  119. CHAN JYW, Huang WB, Liu DL
    Reply to Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: multicenter study from an endemic area in Southern China.
    Cancer. 2018 Oct 21. doi: 10.1002/cncr.31815.

  120. BAUML JM, Vinnakota R, Anna Park YH, Bates SE, et al
    Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of veterans health affairs data.
    Cancer. 2018 Oct 20. doi: 10.1002/cncr.31816.
    PubMed     Abstract available

  121. XIANG M, Holsinger FC, Colevas AD, Chen MM, et al
    Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results-Medicare analysis.
    Cancer. 2018 Oct 17. doi: 10.1002/cncr.31708.
    PubMed     Abstract available

  122. BAUMAN JE, Duvvuri U, Thomas S, Gooding WE, et al
    Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives.
    Cancer. 2018 Oct 6. doi: 10.1002/cncr.31651.
    PubMed     Abstract available

  123. SABA NF, Mendenhall WM, Hutcheson K, Suarez C, et al
    Salvage Surgery for Squamous Cell Carcinoma of the Head and Neck in the Era of Immunotherapy: Is It Time to Clarify Our Guidelines?
    Cancer. 2018 Oct 5. doi: 10.1002/cncr.31717.

    August 2018
  124. SARAFIM-SILVA BAM, Duarte GD, Sundefeld MLMM, Biasoli ER, et al
    Childhood Trauma Is Predictive for Clinical Staging, Alcohol Consumption, and Emotional Symptoms in Patients With Head and Neck Cancer.
    Cancer. 2018 Aug 6. doi: 10.1002/cncr.31597.
    PubMed     Abstract available

    June 2018
  125. GRABOYES EM, Ellis MA, Li H, Kaczmar JM, et al
    Racial and ethnic disparities in travel for head and neck cancer treatment and the impact of travel distance on survival.
    Cancer. 2018 Jun 22. doi: 10.1002/cncr.31571.
    PubMed     Abstract available

    May 2018
  126. XIAO C, Beitler JJ, Higgins KA, Glazer T, et al
    Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer.
    Cancer. 2018 May 9. doi: 10.1002/cncr.31537.
    PubMed     Abstract available

  127. HO AS, Kim S, Tighiouart M, Mita A, et al
    Quantitative survival impact of composite treatment delays in head and neck cancer.
    Cancer. 2018 May 9. doi: 10.1002/cncr.31533.
    PubMed     Abstract available

  128. WEISS JM, Grilley-Olson JE, Deal AM, Zevallos JP, et al
    Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck.
    Cancer. 2018 May 9. doi: 10.1002/cncr.31526.
    PubMed     Abstract available

    April 2018
  129. GUERRIERO MK, Redman MW, Baker KK, Martins RG, et al
    Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial.
    Cancer. 2018 Apr 18. doi: 10.1002/cncr.31407.
    PubMed     Abstract available

  130. WIRTH LJ, Tahara M, Robinson B, Francis S, et al
    Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT).
    Cancer. 2018 Apr 14. doi: 10.1002/cncr.31344.
    PubMed     Abstract available

  131. TOTA JE, Engels EA, Madeleine MM, Clarke CA, et al
    Risk of oral tongue cancer among immunocompromised transplant recipients and human immunodeficiency virus-infected individuals in the United States.
    Cancer. 2018 Apr 12. doi: 10.1002/cncr.31359.
    PubMed     Abstract available

    March 2018
  132. HU J, Bao C, Gao J, Guan X, et al
    Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31318.
    PubMed     Abstract available

    February 2018
  133. ROCHE AM, Fedewa SA, Shi LL, Chen AY, et al
    Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
    Cancer. 2018 Feb 6. doi: 10.1002/cncr.31252.
    PubMed     Abstract available

    January 2018
  134. ZIMMARO LA, Sephton SE, Siwik CJ, Phillips KM, et al
    Depressive symptoms predict head and neck cancer survival: Examining plausible behavioral and biological pathways.
    Cancer. 2018 Jan 22. doi: 10.1002/cncr.31109.
    PubMed     Abstract available

  135. NIKIFOROVA MN, Mercurio S, Wald AI, Barbi de Moura M, et al
    Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
    Cancer. 2018 Jan 18. doi: 10.1002/cncr.31245.
    PubMed     Abstract available

  136. WEEKS KS, Kahl AR, Lynch CF, Charlton ME, et al
    Racial/ethnic differences in thyroid cancer incidence in the United States, 2007-2014.
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31229.
    PubMed     Abstract available

  137. XIAO R, Ward MC, Yang K, Adelstein DJ, et al
    Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.
    Cancer. 2018 Jan 9. doi: 10.1002/cncr.31213.
    PubMed     Abstract available

  138. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    PubMed     Abstract available

  139. SAWABE M, Ito H, Takahara T, Oze I, et al
    Heterogeneous impact of smoking on major salivary gland cancer according to histopathological subtype: A case-control study.
    Cancer. 2018;124:118-124.
    PubMed     Abstract available

  140. NEUWIRTH MG, Bierema C, Sinnamon AJ, Fraker DL, et al
    Trends in major upper abdominal surgery for cancer in octogenarians: Has there been a change in patient selection?
    Cancer. 2018;124:125-135.
    PubMed     Abstract available

    December 2017
  141. ROTH MY, Witt RL, Steward DL
    Molecular testing for thyroid nodules: Review and current state.
    Cancer. 2017 Dec 26. doi: 10.1002/cncr.30708.
    PubMed     Abstract available

  142. DAHLSTROM KR, Anderson KS, Field MS, Chowell D, et al
    Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Cancer. 2017;123:4886-4894.
    PubMed     Abstract available

  143. CHIN RI, Rao YJ, Hwang MY, Spencer CR, et al
    Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil.
    Cancer. 2017;123:4594-4607.
    PubMed     Abstract available

    November 2017
  144. ALI SM, Ross JS, Wang K
    Reply to Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.
    Cancer. 2017 Nov 22. doi: 10.1002/cncr.31132.

  145. LUI VWY, To KF, Lo KW
    Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.
    Cancer. 2017 Nov 22. doi: 10.1002/cncr.31131.

  146. ECONOMIDES MP, Amit M, Mahale PS, Hosry JJ, et al
    Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer.
    Cancer. 2017 Nov 17. doi: 10.1002/cncr.31146.
    PubMed     Abstract available

  147. PRINTZ C
    First person: Maura L. Gillison, MD, PhD: The researcher who found the link between the human papillomavirus and head and neck cancers continues to lead new discoveries in the field.
    Cancer. 2017;123:4307.

  148. LANG KUHS KA, Kreimer AR, Trivedi S, Holzinger D, et al
    Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Cancer. 2017;123:4382-4390.
    PubMed     Abstract available

  149. GUPTA A, Sonis ST, Schneider EB, Villa A, et al
    Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31095.
    PubMed     Abstract available

  150. HOBAN CW, Beesley LJ, Bellile EL, Sun Y, et al
    Individualized outcome prognostication for patients with laryngeal cancer.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31087.
    PubMed     Abstract available

  151. CHANDLER JB, Colunga M, Prasad ML, Callender GG, et al
    Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: Implications for patient management.
    Cancer. 2017;125:865-875.
    PubMed     Abstract available

    October 2017
  152. HUANG WB, Chan JYW, Liu DL
    Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: Multicenter study from an endemic area in Southern China.
    Cancer. 2017 Oct 26. doi: 10.1002/cncr.31031.
    PubMed     Abstract available

    The tumor genome in human immunodeficiency virus-related head and neck cancer: Exploitable targets?
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.31059.

  154. GLEBER-NETTO FO, Zhao M, Trivedi S, Wang J, et al
    Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.31063.
    PubMed     Abstract available

  155. AMIT M, Tam S, Abdelmeguid AS, Roberts DB, et al
    Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma.
    Cancer. 2017 Oct 17. doi: 10.1002/cncr.31083.
    PubMed     Abstract available

  156. SHEN CJ, Hu C, Ladra MM, Narang AK, et al
    Socioeconomic factors affect the selection of proton radiation therapy for children.
    Cancer. 2017;123:4048-4056.
    PubMed     Abstract available

  157. WANG Z, Cheng Y, Abraham JM, Yan R, et al
    RNA sequencing of esophageal adenocarcinomas identifies novel fusion transcripts, including NPC1-MELK, arising from a complex chromosomal rearrangement.
    Cancer. 2017;123:3916-3924.
    PubMed     Abstract available

  158. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    PubMed     Abstract available

  159. CAPARROTTI F, Huang SH, Lu L, Bratman SV, et al
    Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Cancer. 2017;123:3691-3700.
    PubMed     Abstract available

  160. GRIFFITH CC, Schmitt AC, Pantanowitz L, Monaco SE, et al
    A pattern-based risk-stratification scheme for salivary gland cytology: A multi-institutional, interobserver variability study to determine applicability.
    Cancer. 2017;125:776-785.
    PubMed     Abstract available

  161. ROHILLA M, Singh P, Rajwanshi A, Gupta N, et al
    Three-year cytohistological correlation of salivary gland FNA cytology at a tertiary center with the application of the Milan system for risk stratification.
    Cancer. 2017;125:767-775.
    PubMed     Abstract available

  162. ROSSI ED, Faquin WC, Baloch Z, Barkan GA, et al
    The Milan System for Reporting Salivary Gland Cytopathology: Analysis and suggestions of initial survey.
    Cancer. 2017;125:757-766.
    PubMed     Abstract available

    September 2017
  163. SACCO AG, Cohen EE
    Serum antibodies open the door to prediction and prognostication in human papillomavirus-related head and neck cancer.
    Cancer. 2017 Sep 26. doi: 10.1002/cncr.30970.

  164. Researchers delve into thyroid cancer disparities in race and age: Incidence of the disease continues to grow, but at a slower rate in some groups.
    Cancer. 2017;123:3431-3432.

  165. MITO JK, Alexander EK, Angell TE, Barletta JA, et al
    A modified reporting approach for thyroid FNA in the NIFTP era: A 1-year institutional experience.
    Cancer. 2017 Sep 13. doi: 10.1002/cncy.21907.
    PubMed     Abstract available

  166. BLUM MURPHY M, Xiao L, Patel VR, Maru DM, et al
    Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience.
    Cancer. 2017 Sep 8. doi: 10.1002/cncr.30953.
    PubMed     Abstract available

  167. SABA NF
    Refining the predictors of outcome in patients with resectable esophageal cancer.
    Cancer. 2017 Sep 8. doi: 10.1002/cncr.30952.

  168. NGUYEN MT, Hu J, Hastings KG, Daza EJ, et al
    Thyroid cancer mortality is higher in Filipinos in the United States: An analysis using National Mortality Records from 2003 through 2012.
    Cancer. 2017 Sep 7. doi: 10.1002/cncr.30958.
    PubMed     Abstract available

  169. RODEN DF, Schreiber D, Givi B
    Triple-modality treatment in patients with advanced stage tonsil cancer.
    Cancer. 2017;123:3269-3276.
    PubMed     Abstract available

    August 2017
  170. GRABOYES EM, Garrett-Mayer E, Ellis MA, Sharma AK, et al
    Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
    Cancer. 2017 Aug 25. doi: 10.1002/cncr.30939.
    PubMed     Abstract available

  171. ZUMSTEG ZS, Luu M, Yoshida EJ, Kim S, et al
    Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base.
    Cancer. 2017 Aug 17. doi: 10.1002/cncr.30933.
    PubMed     Abstract available

  172. CHOI YM, Kim WG, Kwon H, Jeon MJ, et al
    Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: Analysis of Korean national data.
    Cancer. 2017 Aug 17. doi: 10.1002/cncr.30943.
    PubMed     Abstract available

  173. ALBERGOTTI WG, Jordan J, Anthony K, Abberbock S, et al
    A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
    Cancer. 2017;123:3132-3140.
    PubMed     Abstract available

  174. MEDHANIE GA, Fedewa SA, Adissu H, DeSantis CE, et al
    Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks.
    Cancer. 2017;123:3116-3124.
    PubMed     Abstract available

  175. ROBIN TP, Jones BL, Gordon OM, Phan A, et al
    A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
    Cancer. 2017;123:3040-3049.
    PubMed     Abstract available

  176. BHATIA AK, Lee JW, Pinto HA, Jacobs CD, et al
    Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).
    Cancer. 2017 Aug 7. doi: 10.1002/cncr.30920.
    PubMed     Abstract available

  177. ROOPER LM, Onenerk M, Siddiqui MT, Faquin WC, et al
    Nodular oncocytic hyperplasia: Can cytomorphology allow for the preoperative diagnosis of a nonneoplastic salivary disease?
    Cancer. 2017;125:627-634.
    PubMed     Abstract available

    July 2017
  178. SANDMAEL JA, Bye A, Solheim TS, Stene GB, et al
    Feasibility and preliminary effects of resistance training and nutritional supplements during versus after radiotherapy in patients with head and neck cancer: A pilot randomized trial.
    Cancer. 2017 Jul 31. doi: 10.1002/cncr.30901.
    PubMed     Abstract available

  179. RENSHAW AA, Gould EW
    Adequate sampling of multiple thyroid nodules by fine-needle aspiration.
    Cancer. 2017 Jul 31. doi: 10.1002/cncy.21904.
    PubMed     Abstract available

  180. CRAMER JD, Speedy SE, Ferris RL, Rademaker AW, et al
    National evaluation of multidisciplinary quality metrics for head and neck cancer.
    Cancer. 2017 Jul 20. doi: 10.1002/cncr.30902.
    PubMed     Abstract available

  181. AN Y, Park HS, Kelly JR, Stahl JM, et al
    The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Cancer. 2017;123:2762-2772.
    PubMed     Abstract available

  182. CHANDRASEKHARAPPA SC, Chinn SB, Donovan FX, Chowdhury NI, et al
    Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Cancer. 2017 Jul 5. doi: 10.1002/cncr.30802.
    PubMed     Abstract available

  183. OHORI NP, Wolfe J, Carty SE, Yip L, et al
    The influence of the noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) resection diagnosis on the false-positive thyroid cytology rate relates to quality assurance thresholds and the application of NIFTP criteria.
    Cancer. 2017 Jul 5. doi: 10.1002/cncy.21892.
    PubMed     Abstract available

  184. MARINA NM, Liu Q, Donaldson SS, Sklar CA, et al
    Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
    Cancer. 2017;123:2551-2560.
    PubMed     Abstract available

  185. LEWIS DR, Chen HS, Cockburn MG, Wu XC, et al
    Early estimates of SEER cancer incidence, 2014.
    Cancer. 2017;123:2524-2534.
    PubMed     Abstract available

    June 2017
  186. LEE AWM, Tung SY, Ng WT, Lee V, et al
    A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
    Cancer. 2017 Jun 29. doi: 10.1002/cncr.30850.
    PubMed     Abstract available

  187. SHERMAN EJ, Dunn LA, Ho AL, Baxi SS, et al
    Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.
    Cancer. 2017 Jun 29. doi: 10.1002/cncr.30861.
    PubMed     Abstract available

  188. DAVID JM, Ho AS, Luu M, Yoshida EJ, et al
    Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30843.
    PubMed     Abstract available

  189. WANG FH, Wang Y, Sun GP, Chen JH, et al
    Efficacy and safety of recombinant human lymphotoxin-alpha derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label, controlled, phase 2b trial.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30845.
    PubMed     Abstract available

  190. CHO M, Oweity T, Brandler TC, Fried K, et al
    Distinguishing parathyroid and thyroid lesions on ultrasound-guided fine-needle aspiration: A correlation of clinical data, ancillary studies, and molecular analysis.
    Cancer. 2017 Jun 16. doi: 10.1002/cncy.21888.
    PubMed     Abstract available

  191. WALTERHOUSE DO, Pappo AS, Meza JL, Breneman JC, et al
    Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Cancer. 2017;123:2368-2375.
    PubMed     Abstract available

  192. KONG L, Zhang Y, Hu C, Guo Y, et al
    Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.
    Cancer. 2017;123:2258-2267.
    PubMed     Abstract available

  193. LIN WC, Ding YF, Hsu HL, Chang JH, et al
    Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
    Cancer. 2017 Jun 13. doi: 10.1002/cncr.30823.
    PubMed     Abstract available

  194. ALI SM, Yao M, Yao J, Wang J, et al
    Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
    Cancer. 2017 Jun 5. doi: 10.1002/cncr.30781.
    PubMed     Abstract available

  195. ROSSI ED, Martini M, Cenci T, Capodimonti S, et al
    The role of thyroid FNA cytology in pediatric malignant lesions: An overview of the literature.
    Cancer. 2017 Jun 5. doi: 10.1002/cncy.21884.
    PubMed     Abstract available

  196. JOHNSON DB, Sullivan RJ, Menzies AM
    Immune checkpoint inhibitors in challenging populations.
    Cancer. 2017;123:1904-1911.
    PubMed     Abstract available

  197. KIM Y, Lee SJ, Lee JY, Lee SH, et al
    Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
    Cancer. 2017;123:1958-1964.
    PubMed     Abstract available

  198. ONENERK AM, Pusztaszeri MP, Canberk S, Faquin WC, et al
    Triage of the indeterminate thyroid aspirate: What are the options for the practicing cytopathologist?
    Cancer. 2017;125.
    PubMed     Abstract available

    May 2017
  199. HANG JF, Westra WH, Cooper DS, Ali SZ, et al
    The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the performance of the Afirma gene expression classifier.
    Cancer. 2017 May 24. doi: 10.1002/cncy.21879.
    PubMed     Abstract available

  200. CATENACCI DV, Ang A, Liao WL, Shen J, et al
    MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
    Cancer. 2017;123:1061-1070.
    PubMed     Abstract available

  201. MALM IJ, Fan CJ, Yin LX, Li DX, et al
    Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Cancer. 2017;123:1768-1777.
    PubMed     Abstract available

  202. GOEPFERT RP, Hutcheson KA, Lewin JS, Desai NG, et al
    Complications, hospital length of stay, and readmission after total laryngectomy.
    Cancer. 2017;123:1760-1767.
    PubMed     Abstract available

  203. LV JW, Chen YP, Huang XD, Zhou GQ, et al
    Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area.
    Cancer. 2017 May 10. doi: 10.1002/cncr.30775.
    PubMed     Abstract available

  204. PAI SI, Faquin WC
    Programmed cell death ligand 1 as a biomarker in head and neck cancer.
    Cancer. 2017 May 4. doi: 10.1002/cncy.21872.

  205. NAIK KB, Liu Y, Goodman M, Gillespie TW, et al
    Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30763.
    PubMed     Abstract available

  206. FAKHRY C, Westra WH, Wang SJ, van Zante A, et al
    The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Cancer. 2017;123:1566-1575.
    PubMed     Abstract available

  207. SHIELD PW, Frost F, Finnimore JL, Wright RG, et al
    External quality assurance in nongynecologic cytology: The Australasian experience.
    Cancer. 2017;125:349-361.
    PubMed     Abstract available

    April 2017
  208. SHAH BR, Griffiths R, Hall SF
    Thyroid cancer incidence among Asian immigrants to Ontario, Canada: a population-based cohort study.
    Cancer. 2017 Apr 25. doi: 10.1002/cncr.30746.
    PubMed     Abstract available

  209. ZUMSTEG ZS, Lok BH, Ho AS, Drill E, et al
    The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Cancer. 2017;123:1345-1353.
    PubMed     Abstract available

  210. VIVERO M, Renshaw AA, Krane JF
    Adequacy criteria for thyroid FNA evaluated by ThinPrep slides only.
    Cancer. 2017 Apr 7. doi: 10.1002/cncy.21858.
    PubMed     Abstract available

  211. BONGIOVANNI M, Mermod M, Canberk S, Saglietti C, et al
    Columnar cell variant of papillary thyroid carcinoma: Cytomorphological characteristics of 11 cases with histological correlation and literature review.
    Cancer. 2017 Apr 3. doi: 10.1002/cncy.21860.
    PubMed     Abstract available

  212. SABRA MM, Sherman EJ, Tuttle RM
    Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma.
    Cancer. 2017 Apr 3. doi: 10.1002/cncr.30690.
    PubMed     Abstract available

  213. D'SOUZA G, Robbins HA
    Sexual and relationship health among survivors of oropharyngeal or oral cavity squamous cell carcinoma.
    Cancer. 2017;123:1092-1094.

    March 2017
  214. BERMAN TA, Schiller JT
    Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Cancer. 2017 Mar 27. doi: 10.1002/cncr.30588.
    PubMed     Abstract available

  215. SINHA P, Haughey BH, Kallogjeri D, Spitznagel EL, et al
    The role of postoperative chemoradiation for oropharyngeal carcinoma: A critical appraisal revisited.
    Cancer. 2017;123:887-888.

    February 2017
  216. DRAHOS J, Ricker W, Pfeiffer RM, Cook MB, et al
    Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER-Medicare data.
    Cancer. 2017;123:657-665.
    PubMed     Abstract available

  217. GAN TR, Nga ME, Lum JH, Wong WM, et al
    Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
    Cancer. 2017 Feb 13. doi: 10.1002/cncy.21823.
    PubMed     Abstract available

  218. WANG H, Hoda RS, Faquin W, Rossi ED, et al
    FNA biopsy of secondary nonlymphomatous malignancies in salivary glands: A multi-institutional study of 184 cases.
    Cancer. 2017;125:91-103.
    PubMed     Abstract available

    January 2017
  219. HUTCHESON KA, Barrow MP, Barringer DA, Knott JK, et al
    Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation.
    Cancer. 2017;123:62-70.
    PubMed     Abstract available

  220. SHER DJ, Rusthoven CG, Khan SA, Fidler MJ, et al
    National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma.
    Cancer. 2017;123:273-282.
    PubMed     Abstract available

  221. COOPER JS, Fortpied C, Gregoire V, Le QT, et al
    The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal revisited.
    Cancer. 2017;123:12-16.

  222. COLLINS GS, Le Manach Y
    Nomograms need to be presented in full.
    Cancer. 2017;123:177-178.

  223. CHOI HC, Xu W, Lee AW
    Reply to Nomograms need to be presented in full.
    Cancer. 2017;123:178-179.

    December 2016
  224. BISHOP JA, French CA, Ali SZ
    Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.
    Cancer. 2016;124:901-908.
    PubMed     Abstract available

    November 2016
  225. JIANG XS, Harrison GP, Datto MB
    Young investigator challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
    Cancer. 2016 Nov 28. doi: 10.1002/cncy.21802.
    PubMed     Abstract available

  226. SOMNAY YR, Yu XM, Lloyd RV, Leverson G, et al
    Notch3 expression correlates with thyroid cancer differentiation, induces apoptosis, and predicts disease prognosis.
    Cancer. 2016 Nov 2. doi: 10.1002/cncr.30403.
    PubMed     Abstract available

    October 2016
  227. HAUGEN BR
    2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?
    Cancer. 2016 Oct 14. doi: 10.1002/cncr.30360.
    PubMed     Abstract available

    September 2016
  228. BIZZARRO T, Martini M, Capodimonti S, Straccia P, et al
    Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification.
    Cancer. 2016 Sep 26. doi: 10.1002/cncy.21777.
    PubMed     Abstract available

    August 2016
  229. SHERMAN SI, Clary DO, Elisei R, Schlumberger MJ, et al
    Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer.
    Cancer. 2016 Aug 15. doi: 10.1002/cncr.30252.
    PubMed     Abstract available

  230. LUBITZ CC, Sosa JA
    The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients.
    Cancer. 2016 Aug 12. doi: 10.1002/cncr.30201.
    PubMed     Abstract available

    July 2016
  231. KU GY, Kriplani A, Janjigian YY, Kelsen DP, et al
    Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma.
    Cancer. 2016;122:2083-90.
    PubMed     Abstract available

  232. HORNE ZD, Glaser SM, Vargo JA, Ferris RL, et al
    Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
    Cancer. 2016;122:2021-30.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.